HEAD AND NECK CUTANEOUS SQUAMOUS CELL CARCINOMA

Clinical trials for HEAD AND NECK CUTANEOUS SQUAMOUS CELL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new HEAD AND NECK CUTANEOUS SQUAMOUS CELL CARCINOMA trials appear

Sign up with your email to follow new studies for HEAD AND NECK CUTANEOUS SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug combo aims to supercharge immune system to fight cancer before surgery

Disease control Recruiting now

This study is testing if adding a new immune-boosting drug (CDX-1140) to an existing immunotherapy (cemiplimab) works better before surgery for advanced head and neck cancer. The goal is to shrink the tumor more effectively, which could lead to less extensive surgery. About 44 pa…

Matched conditions: HEAD AND NECK CUTANEOUS SQUAMOUS CELL CARCINOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 30, 2026 14:31 UTC

HEAD AND NECK CUTANEOUS SQUAMOUS CELL CARCINOMA

Get alerted when new HEAD AND NECK CUTANEOUS SQUAMOUS CELL CARCINOMA trials appear

New drug combo aims to supercharge immune system to fight cancer before surgery